Related Experiment Video
Updated: Oct 13, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Effects of hypercapnia on endocrine and metabolic responses to anaesthesia in ponies
1Department of Clinical Veterinary Medicine, University of Cambridge.
Abstract:
Some metabolic and endocrine effects of hypercapnia were studied in six ponies during halothane anaesthesia with neuromuscular blockade and controlled ventilation. Each was anaesthetised twice, once with a 40-minute-period of hypercapnia (10 kPa) and once when normocapnia (5.3 kPa) was maintained throughout two hour's anaesthesia. Routine cardiovascular monitoring was performed and blood samples were taken for assay of cortisol, insulin, glucose, lactate, muscle and liver enzymes and total protein. Anaesthesia induced hypotension and lacticacidaemia which were slightly ameliorated during hypercapnia. Hyperglycaemia was more marked during hypercapnia. Plasma cortisol increased in a similar manner in both groups and insulin tended to decrease. There were no major changes in the other variables measured. It was concluded that 40 minutes of hypercapnia during halothane anaesthesia in ponies may have improved perfusion and did not markedly alter the stress response.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
08:41Hypercapnic Hyperventilation to Accelerate Emergence from Inhaled Volatile Anesthetics: A Practical Method Using Standard Hospital Equipment
Published on: June 26, 2026
Related Concept Videos
Hypothalamic-Pituitary Axis
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Inhalational Anesthetics: Overview
Hyperpnea and Hyperventilation
Acute Respiratory Failure-III
Cushing Syndrome II: Pathophysiology